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Our current understanding on the molecular mechanisms by which sustained
compression induces skeletal muscle injury is very limited. This study aimed to test the
hypothesis that activation of SIRT1 by the natural antioxidant resveratrol could deactivate
apoptotic and catabolic signaling in skeletal muscle exposed to moderate compression.
Two cycles of 6-h constant pressure at 100mmHg was applied to the tibialis region
of right, but not left hindlimbs of Sprague Dawley rats pre-treated with DMSO (vehicle
control) or resveratrol with/without sirtinol. Skeletal muscle tissues lying underneath
and spatially corresponding to the compressed sites were collected for analyses.
Resveratrol prevented the compression-induced manifestations of pathohistological
damages including elevations of the number of interstitial nuclei and area of interstitial
space and ameliorated oxidative damages measured as 4-hydroxy-2-nonenal (4HNE)
and nitrotyrosine in skeletal muscle. In parallel, resveratrol augmented the expression level
and activity of SIRT1 and phosphorylation levels of Foxo3a and Akt while suppressed
the increases in protein abundances of p53, Bax, MAFbx, and ubiquitin, enzymatic
activities of caspase 3 and 20S proteasome, and apoptotic DNA fragmentation in
the compressed muscle. These favorable myoprotective effects of resveratrol were
diminished upon pharmacological blockade of SIRT1 by using sirtinol. These novel data
support the hypothesis that the anti-apoptotic and anti-catabolic effects of resveratrol on
compression injury in skeletal muscle required the action of SIRT1.
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INTRODUCTION
Pressure ulcer (PU) refers to tissue ulceration at epidermal and/or sub-dermal levels in response
to sustained compression by supporting interfaces such as beds, wheelchairs and prosthetics.
It has been unraveled in a retrospective analysis that PU was diagnosed in 4.5% of patients
aged between 75 and 85 years upon admission in which 16.7% of these patients developed new
ulcers during hospitalization; leading to a ∼2.4-fold increase in length of hospital stay (Moore,
2013). Screening of high-risk patients is also difficult; provided that late-stage ulcers often are not
diagnosed until open wound beds and concomitant exposure of tendons, skeletal muscle, and/or
bones become evident (EPUAP, 2009). Although gross factors including friction and shear were
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correlated highly with abnormal heel scans, the efficacy of
diagnosis was often challenged by the presence of skin alterations
(Helvig and Nichols, 2012). Taken together the fact that current
interventions for chronic venous leg ulcers depend largely on
wound management whereas a considerable number of those
are only palliative (Lazarus et al., 2014), understanding the
molecular mechanisms of PU is of high importance in drug target
identification and design of therapeutics.
The concept of “Deep Tissue Injury” was introduced by the
National Pressure Ulcer Advisory Panel (NPUAP) to recognize
the form of PU that develops as a consequence of damages of
the underlying soft tissues (Stausberg and Kiefer, 2009). Earlier
experiments have identified a modest drop in temperature in
the compressed skeletal muscle secondary to the occlusion of
microvasculature (Linder-Ganz and Gefen, 2007). However, it
was proposed that the effectiveness of thermal monitoring could
have been precluded by existing variations of body composition
among patients and concurrent heat release in surrounding
regions with inflammation (Gefen, 2009). While the pathogenic
mechanisms of deep tissue injury is largely unknown, a pioneer
study has reported that compression stress induced substantial
elevations of cell death and stiffness in the skeletal muscle in a
dose-dependent fashion (Gefen et al., 2005). Corroborating data
from our laboratory have indicated that apoptosis was activated
in the skeletal muscle of rats exposed to sustained, moderate
compression. Importantly, the increases in apoptotic markers
measured as TUNEL index, apoptotic DNA fragmentation and
cleavage of caspase 3 in the compressed muscle were observed
in circumvent with the presence of pathohistological damages;
suggesting that apoptosis might mediate the pathogenesis of
deep tissue injury (Siu et al., 2009). This speculation was
supported by the data showing that the aforementioned changes
were blunted significantly in response to the administration
of z-VAD-fmk, which is a caspase inhibitor (Teng et al.,
2011).
The thought that oxidative stress is a stimulus of apoptotic
cell death prompted us to study the role of oxidative damages
in compression-induced injury in the skeletal muscle. We
have demonstrated recently that the immunoreactivities of
4HNE, nitrotyrosine and 8-OHdG, which are markers indicative
of lipid peroxidation, protein nitrosylation and oxidation of
guanine nucleotides respectively, were increased remarkably in
the compressed muscle (Sin et al., 2013). In contrast, these
elevations were alleviated significantly in animals pre-treated
with resveratrol, which is a natural antioxidant commonly
found in grapes and berries (Sin et al., 2013). Sirtuin 1
(SIRT1) is the mammalian ortholog of sir2 in yeasts, in
which its activation by resveratrol was accompanied by
increased genomic stability and lifespan extension (Howitz
et al., 2003). Another line of evidence has suggested that
resveratrol prevented the elevations of muscle atrophic factors
including MAFbx and MuRF-1 in cultured myotubes under
catabolic challenge with dexamethasone (Alamdari et al., 2012).
Intriguingly, transcriptional silencing of SIRT1 was found to
abolish the protective effects of resveratrol in dexamethasone-
treated myotubes (Alamdari et al., 2012). Hence, this study
aimed to investigate whether resveratrol would suppress the
apoptotic/catabolic machinery in skeletal muscle through a
SIRT1-dependent mechanism in response to the induction of
compression injury.
MATERIALS AND METHODS
Induction of Compression Injury in the
Skeletal Muscle
Male Sprague-Dawley rats (n = 4 per group) were subject to
a compression protocol that was established by our laboratory
(Sin et al., 2013). Animals were first anesthetized with a mixture
of ketamine and xylazine prior to the shaving of hairs of the
right hindlimbs. A compression indentor was used to apply a
constant pressure of 100mmHg to the tibialis region of the right
hindlimb for 6 h by which the compression force was monitored
by a three-axial transducer. This was followed by 18 h of rest
whereas the left hindlimb was uncompressed serving as intra-
animal control. Complete anesthesia was maintained during
the entire compression period through the delivery of 1/3 the
anesthetic mixture when deemed necessary. The rats were then
exposed to the same protocol the following day such that two
cycles of 6-h compression were achieved before sacrifice for the
collection of skeletal muscle. All procedures of animal husbandry
and compression were conducted in full accordance with the
approval of the Animal Subjects Ethics Subcommittee of The
Hong Kong Polytechnic University.
Administration of Drugs of Interest
The animals were randomly assigned to receive one of
the following treatments: DMSO vehicle, resveratrol or a
combination of resveratrol and sirtinol (a SIRT1 inhibitor) of
either dose at 2 or 5mg kg−1 day−1. Resveratrol (RSV) was
injected intraperitoneally at a dose of 25mg kg−1 day−1 (Sin
et al., 2013) in both resveratrol and resveratrol and sirtinol
combination groups. In the combination treatment group, 2 or
5mg kg−1 day−1 sirtinol (Sin et al., 2015a) was administered
immediately through the intraperitoneal route after resveratrol
injection. The corresponding amount of DMSO vehicle was
administered likewise in the DMSO group. Compression was
initiated at once when all the drugs were delivered.
Haematoxylin and Eosin Staining
Ten micrometer thick cross sections of skeletal muscle lying
underneath the skin of compressed regions were prepared
in a freezing cryostat at −20◦C. Air-dried sections were
then fixed with 10% formalin (HT-5011, Sigma-Aldrich, St
Louis, MO, USA) at room temperature for 10min followed
by counter-staining in Mayer’s haematoxylin solution (MHS-
1, Sigma-Aldrich) for 45min and 1% eosin in CaCl2 (31,8906,
Sigma-Aldrich) for 1min. Numbers of interstitial nuclei and
muscle nuclei and area of interstitial space were quantified
through the use of Image J software of National Institutes of
Health. All the histological data were presented as average results
from three random, non-overlapping image fields captured
under a 20x objective.
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Immunoblotting
Cytoplasmic and nuclear proteins were extracted from muscle
homogenates as described (Sin et al., 2013). Thirty micrograms
of proteins were loaded and separated on 10% polyacrylamide
gels followed by transfer to PVDF membranes (Immobilon P,
Millipore, Billerica, MA, USA). The membranes were blocked
for 1 h at room temperature followed by an overnight incubation
with the following primary antibodies at 4◦C: anti-SIRT1 (15,404,
Santa Cruz, Santa Cruz, CA, USA), anti-nitrotyrosine (32,731,
Santa Cruz), anti-4-hydroxy-2-nonenol or anti-4HNE (24,327,
Oxis), anti-p-Foxo3 (9466, Cell Signaling, Beverly, MA, USA),
anti-Foxo3 (97-702, Millipore), anti-p-Akt (9271, Cell Signaling),
anti-Akt (9272, Cell Signaling), anti-p53 (56,179, Santa Cruz),
anti-Bax (493, Santa Cruz), anti-Bim (11,425, Santa Cruz), anti-
MAFbx (33,782, Santa Cruz), anti-MuRF-1 (32,920, Santa Cruz),
and anti-ubiquitin (3936, Cell Signaling). The membranes were
then incubated with the corresponding secondary antibodies for
1 h. After washing, chemiluminscent signal was then detected
using a Kodak 4000R Pro camera with the application of
luminal reagent (NEL103001EA, Perkin Elmer, Waltham, MA,
USA). All protein expression data were normalized to the signal
of β-tubulin (T0198, Sigma-Aldrich) except that of nuclear
Foxo3a; of which normalization to histone 2b (07-371, Upstate,
Charlottesville, VA, USA) was performed.
Real Time PCR Analyses
RNA extraction, reverse transcription and real time PCR were
performed according to our previous publication (Sin et al.,
2013). The following forward and reverse primers were used:
SIRT1: F 5′-TTTCAGAACCACCAAAGCG-3′, R 5′-TCCC
ACAGGAAACAGAAACC-3′; Nampt: F 5′-GATTCTGGAAAT
CCGCTCGA-3′, R 5′-TGACTCTAAGGTAAGGTGGCAGC-3′;
PSMA2: F 5′-TGGGTCCAGATTACAGAGTC-3′, R 5′-ATGG
ACGAACACCACCTGA-3′; PSMA5: F 5′-GGACCTTCGTACA
GTGTGAT-3′, R 5′-GCTTCTCCTCCATGACTTGC-3′ and
PSMB4: F 5′-GTGTAGCTTATGAAGCCCCTTCA-3′, R 5′-ACT
CAGCACCGGTTGCTTCT-3′. All data of gene expression
were presented as relative fold changes to that of β-tubulin:
F 5′-CCTGCTCATCAGCAAGATTCG-3′, R 5′-GTGGTGA
GCTTAAGGGTACGG-3′.
SIRT1 Deacetylation Assay
The deacetylase activity of SIRT1 was assessed by a fluorometric
kit in accordance with the instructions of manufacturer (Cyclex,
Nagoya, Japan). Each reaction was initiated by the addition
of 5µl protease inhibitor-free muscle protein extracts under
thorough mixing. Fluorescence intensity was measured by a
microplate fluorometer for every 2-min time interval. The
data were expressed as the rate of reaction per 1mg of
proteins.
Caspase 3 Activity Assay
Protease activity of caspase 3 activity was assessed by a
fluorometric approach involving the use of caspase 3 substrate
DEVD-AFC (1007-200, Biovision, Milpitas, CA, USA). All
procedures were adhered to those as described (Teng et al., 2011).
Cell Death Elisa Assay
Cell death ELISA assay (Roche Diagnostics, Indianapolis, IN,
USA) was conducted to determine apoptotic DNA fragmentation
according to the manufacturer’s recommendations.
Proteasome Activity Assay
The activity of proteasome activity was measured based on the
release of fluorescent AMC from its tagged peptide substrate in
the presence of proteolytic activity. All procedures were carried
out under the recommendations of the manufacturer (K245-100,
Biovision).
Statistical Analyses
Statistical analyses were conducted using the SPSS 22.0 software
package (IBM, Chicago, IL, USA). A normality test was
performed to examine data distributions. All data were expressed
as means ± standard error of the mean (SEM). Comparisons
were made by One-way ANOVA followed by Tukey post-hoc test.




Representative micrographs revealing the effects of moderate
compression and treatment of interest on muscle histology
are shown (Figure 1A). Our histological analyses indicated
that the number of interstitial nuclei was 4.6 folds higher
in the compressed muscle relative to the control muscle of
DMSO vehicle group (Figure 1B). This compression-induced
increase was suppressed by resveratrol, but not in combination
with both doses (2 and 5mg kg−1) of sirtinol (Figure 1B).
However, the number of muscle nuclei between control and
compressed muscles did not differ significantly among all the
treatment groups (Figure 1C). In addition, the area of interstitial
space in compressed muscles was increased by 2.4 folds
compared with control muscles in DMSO group (Figure 1D).
Resveratrol, but not in conjunction with sirtinol of either dose,
hampered the elevation of area of interstitial space in muscles
exposed to moderate compression (Figure 1D). Based on the
observation that the inhibitory effects of sirtinol (i.e., increases
in number of interstitial nuclei and area of interstitial space in
compressed muscles) were more prominent with higher doses
(Figures 1B,D), muscle samples arose from 5mg kg−1 sirtinol
treatment were then used for subsequent analyses. Furthermore,
the distribution of cross sectional area of muscle fibers did
not change after compression irrespective of the drugs studied
(Figure 1E).
Inverse Regulation of SIRT1 and Oxidative
Stress in the Compressed Muscle
In DMSO vehicle-treated animals, the protein content of
SIRT1 was reduced significantly by 55% in the skeletal muscle
in response to compression (Figure 2A). This compression-
induced reduction was abolished by resveratrol, but not in
conjunction with sirtinol (Figure 2A). The reduction of SIRT1
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FIGURE 1 | Histological analyses. Resveratrol abolished aberrant muscle morphology induced by compression but this effect was reversed by sirtinol (A). The
reduction of number of interstitial nuclei by resveratrol in the compressed muscle was mitigated by sirtinol (B). No compression or treatment effects were observed for
the number of muscle nuclei (C). The elevation of area of interstitial space induced by compression was alleviated only by resveratrol alone (D). Neither did
compression nor drug treatments affect the cross-sectional area of muscle fibers (E). *p < 0.05, compressed muscles compared to uncompressed control muscles;
#p < 0.05, resveratrol relative to DMSO; +p < 0.05, resveratrol + sirtinol compared with resveratrol.
protein in compressed muscles of DMSO-treated rats was
followed by a 64% attenuation of SIRT1 deacetylase activity
(Figure 2B). This reduction was blunted by resveratrol only in
the absence of sirtinol (Figure 2B). The transcript level of SIRT1
between compressed and uncompressed muscles, however, did
not differ significantly in all treatment groups (Figure 2C). The
mRNA content of Nampt was reduced significantly by 76% in
response to moderate compression; this down-regulation was
reversed by resveratrol regardless of administration with sirtinol
(Figure 2D). Nitrotyrosine and 4HNE are markers of oxidative
stress indicative of protein nitrosylation and lipid peroxidation,
respectively. The levels of nitrotyrosine and 4HNE were 2.2 folds
and 1.9 folds higher in the compressed muscle compared with
control muscle in the DMSO group whereas these elevations
were not observed in the resveratrol group (Figures 2E,F). The
reductions of nitrotyrosine and 4HNE induced by resveratrol,
however, were reversed upon SIRT1 inhibition (Figures 2E,F).
Resveratrol Inhibited Aberrant
Phosphorylation Status of Foxo3a/Akt
The phosphorylation level of Foxo3a was reduced significantly
by 62% in the skeletal muscle after compression whereas
this reduction was ameliorated by resveratrol administration
(Figure 3A). The cytoplasmic protein content of Foxo3a was
decreased by 39% in compressed muscles of vehicle-treated
rats but not in their counterparts treated with resveratrol
(Figure 3B). The phosphorylation ratio of Foxo3a in the vehicle
group remained unchanged after compression whereas this ratio
was decreased by 60% in resveratrol-treated rats (Figure 3C).
In contrast, the nuclear content of Foxo3a was 9.6 holds
higher in compressed muscles compared with control muscles
in the vehicle group whereas this elevation was abolished
by resveratrol (Figure 3D). Of note, these resveratrol-induced
alterations were antagonized by combination treatment with
sirtinol (Figures 3A,B,D). Moderate compression diminished
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FIGURE 2 | SIRT1 and oxidative damages. Resveratrol, but not in conjunction with sirtinol (5mg kg−1), blunted the decrease in protein level of SIRT1 in
compressed muscles (A). Similar observations were seen with the deacetylase activity of SIRT1 (B). The mRNA content of SIRT1 (C), but not Nampt (D), was
unaffected by compression. The compression-induced increases in nitrotyrosine (E) and 4HNE (F) were attenuated by resveratrol only in the absence of SIRT1
inhibition. *p < 0.05, compressed muscles (comp) compared to uncompressed control muscles (con); #p < 0.05, resveratrol relative to DMSO; +p < 0.05,
resveratrol + sirtinol compared with resveratrol.
the phosphorylation level, but not the total protein abundance of
Akt by 83% (Figure 3E). This compression-induced reduction,
however, was mitigated by resveratrol only in the absence of
sirtinol (Figure 3E).
SIRT1 Mediated the Anti-apoptotic Effects
of Resveratrol
In the DMSO vehicle group, the protein abundances of
p53 and Bax were remarkably higher in the compressed
muscle relative to control muscle by 3.7 folds and 5.2
folds, respectively (Figures 4A,B). These up-regulations were
prevented by resveratrol, but not in combination with sirtinol
(Figures 4A,B). The protein expression of Bim was elevated
remarkably by 5.3 folds in the compressed muscle but this
increase was not affected by any of the treatments (Figure 4C).
Compared with control muscles, caspase 3 activity and apoptotic
DNA fragmentation were 2.8 folds and 9.0 folds higher
respectively in compressed muscles (Figures 4D,E). Resveratrol,
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FIGURE 3 | Phosphorylations of Foxo3a and Akt. The decrease in phosphorylated Foxo3a in compressed muscle was blunted by resveratrol, but not in
combination with sirtinol (5mg kg−1) (A). Resveratrol augmented the cytoplasmic level of Foxo3a (B) while suppressed phosphorylation ratio of Foxo3a (C) and
nuclear Foxo3a (D) in compressed muscles. The attenuation of phospho-Akt induced by compression was hampered by resveratrol in the absence of sirtinol (E).
*p < 0.05, compressed muscles (comp) compared to uncompressed control muscles (con); #p < 0.05, resveratrol relative to DMSO; +p < 0.05, resveratrol + sirtinol
compared with resveratrol.
but not in combination with sirtinol, reversed the increases in
caspase 3 activity and apoptotic DNA fragmentation induced by
compression injury (Figures 4D,E).
Suppression of Catabolic Markers by
Resveratrol Requires SIRT1
The protein content of MAFbx was elevated abruptly by
19.4 folds in the skeletal muscle in response to moderate
compression (Figure 5A). This compression-induced increase
was mitigated significantly by resveratrol only in the absence of
SIRT1 inhibition (Figure 5A). However, the protein expression
of MuRF-1 was not significantly different between control
and compressed muscles of all treatment groups (Figure 5B).
Protein ubiquitination was up-regulated by 2.5 folds in
compressed muscles relative to uncompressed controls
whereas this increase was reversed by resveratrol, but not
in combination with sirtinol (Figure 5C). The proteasomal
activity in compressed muscles was 5.8 folds higher relative
to control muscles of DMSO group whereas this increase
was abrogated by resveratrol, but not in conjunction with
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FIGURE 4 | Signal transduction of apoptosis. Our immunoblot analyses revealed the suppressive effects of resveratrol, but not in conjunction with sirtinol (5mg
kg−1), on the expression of p53 (A) and Bax (B) in compressed muscles. The up-regulation of Bim by moderate compression was unaffected by any of the drug
studied (C). The anti-apoptotic effects of resveratrol were confirmed by the determination of caspase 3 activity (D) and apoptotic DNA fragmentation (E). *p < 0.05,
compressed muscles (comp) compared to uncompressed control muscles (con); #p < 0.05, resveratrol relative to DMSO; +p < 0.05, resveratrol + sirtinol compared
with resveratrol.
sirtinol treatment (Figure 5D). We also examined the alpha
2, alpha 5, and beta 4 subunits of proteasome at transcript
level in which were denoted thereafter as PSMA2, PSMA5, and
PSMB4, respectively. The mRNA levels of PSMA2 and PSMA5
were neither affected by compression nor any of the drugs
studied (Figures 5E,F). The transcript content of PSMB4 was
increased significantly by 91% in compressed muscles relative to
uncompressed controls; this compression-induced increase was
antagonized by resveratrol, but not in combination with sirtinol
(Figure 5G).
DISCUSSION
This study has provided the novel insight that restoration of
SIRT1 activity by resveratrol protected against the development
of pathohistological damages in the skeletal muscle induced
by moderate compression through the inactivation of
apoptotic/catabolic pathways. Protein kinase B, also known
as Akt1, is a well-accepted survival signal. In agreement
with the observation that restoration of Akt phosphorylation
in the skeletal muscle averted the productions of cleaved
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FIGURE 5 | Markers of muscle catabolism. In the absence of SIRT1 inhibition, resveratrol down-regulated MAFbx in the compressed muscle (A). The protein
expression of MuRF-1 was not affected by compression or any of the treatments (B). Resveratrol, but not concomitantly with sirtinol (5mg kg−1), suppressed the
compression-induced elevations of ubiquitinated proteins (C) and proteasomal activity (D). The transcript levels of proteasomal alpha 2 subunit; PSMA2 (E), alpha 5
subunit; PSMA5 (F) and beta 4 subunit; PSMB4 (G) were determined by qPCR. *p < 0.05, compressed muscles (comp) compared to uncompressed control muscles
(con); #p < 0.05, resveratrol relative to DMSO; +p < 0.05, resveratrol + sirtinol compared with resveratrol.
caspase 3 and 14-kDa actin fragment after angiotensin-II
infusion (Song et al., 2005), resveratrol maintained the level
of phosphorylated Akt and inhibited markers of apoptosis
and muscle degradation in compressed muscles. The increase
in interstitial space in response to compression could be a
consequence of accumulation of tissue fluid that accompanied
infiltration activities during inflammatory response. Earlier
study has shown that the mRNA level of TNF-α, a member of
inflammatory signaling was elevated with lesion size in a rat
model of spinal cord injury (Lee et al., 2003). A former work from
our laboratory has demonstrated consistently that the muscle
contents of ED1 and ED2, which are macrophage markers, were
elevated after compression (Teng et al., 2011). Recent research
has exhibited that resveratrol blunted the level of TNF-α in
the skeletal muscle of rats with chronic obstructive pulmonary
disease (Qi et al., 2014); although whether the anti-inflammatory
property of resveratrol would account for its modulatory effects
on the reduction of interstitial space in compressed muscles shall
be addressed in the future.
Elevations of apoptotic and catabolic signaling pathways
have been implicated in various muscle pathologies. Forced-
expression of Bcl2 was observed to ameliorate the loss of
grip strength in a mouse model of oculopharyngeal muscular
dystrophy (Davies and Rubinsztein, 2011). Supporting the
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inhibitory role of Bcl2 in Bax/Bak-mediated apoptosis (Dominov
et al., 2005), the immunoreactivities of diffuse cytochrome c and
active caspase 3 were concomitantly attenuated in dystrophic
muscles expressing the Bcl2 transgene (Davies and Rubinsztein,
2011). The thought that anti-catabolic interventions would
alleviate muscle injury was corroborated by a study showing
that genetic inactivation of cellular inhibitor of apoptosis 1
(cIAP1), which is an ubiquitin ligase, reduced significantly the
centronucleation of muscle fibers and infiltration of macrophages
in soleus muscles of dystrophin-deficient mice (Enwere et al.,
2013). Indeed, our laboratory has previously shown that markers
related to apoptotic signaling and muscle degradation were
elevated in the skeletal muscle of rats exposed to moderate
compression (Siu et al., 2009, 2011). The present work is the
first attempt to demonstrate that resveratrol, which is a natural
polyphenol in grapes and red wine prevented the increases in
protein abundances of p53, Bax, MAFbx, and ubiquitin and
enzymatic activities of caspase 3 and proteasome induced by
compression injury in the skeletal muscle. These results were
in line with those reported with pharmacological inhibition of
caspases (Teng et al., 2011) and proteasome (Siu et al., 2011).
To our surprise, the increase in Bim protein after compression
was not reversed by acute resveratrol treatment; this observation
does not agree with our recent efforts showing that long-term
resveratrol supplementation blunted the protein level of Bim in
the senescent heart (Sin et al., 2014) and skeletal muscle (Sin
et al., 2015b). While these discrepancies could be ascribed to
the differences in the duration of resveratrol treatment, there are
also evidences that resveratrol induced accumulation of Bim in
the mitochondria and p53-independent cell death (Gogada et al.,
2011); hence endeavors further efforts to dissect the regulatory
mechanisms of Bim by resveratrol in muscle disorders.
It is thought that the pleiotropic actions of resveratrol
are mediated largely by sirtuin 1 (SIRT1). Transcriptional
repression of SIRT1 has been shown to diminish the anti-
hypertrophic effects of resveratrol in cardiomyocytes stimulated
with phenylephrine (Kuno et al., 2013). Previous studies also
revealed that Nox4, which is a catalytic subunit of the oxidant-
producing NADPH oxidase, was up-regulated in C2C12 cultures
treated with SIRT1 siRNA (Hori et al., 2011). These data were
in concordant with the findings exhibiting that resveratrol
reduced the expression of acetyl-histone H3, a marker indicative
of increased SIRT1 deacetylase activity; and abundances of
nitrotyrosine and 8-OHdG in dystrophic muscles (Hori et al.,
2011). While our previous efforts have shown that resveratrol
ameliorated the compression-induced increases in nitrotyrosine
and 4HNE in the skeletal muscle (Sin et al., 2013), here we further
demonstrated that these resveratrol-induced suppressions were
abolished by co-administration with sirtinol; thereby indicating
a modulatory role of SIRT1 in the pathogenesis of deep tissue
injury. Notably, our findings that the protein level of SIRT1
was reduced with concomitant up-regulation of MAFbx, which
is an ubiquitin-related E3 ligase, in response to compression
were consistent with those reported with food deprivation
(Lee and Goldberg, 2013). The notion that SIRT1 inhibited
muscle degradation was strengthened by the observation that
forced expression of SIRT1, but not its deacetylation-defective
mutant, abrogated the increase in Bnip3 transcript (Lee and
Goldberg, 2013). It is also noteworthy that resveratrol enhanced
the protein expression and deacetylase activity, but not the
mRNA content of SIRT1 in compressed muscles. Despite that
the reasons underlying this inconsistent mode of regulation
are not understood, over-expression of miR-22 in the heart
induced a remarkable decrease in SIRT1 protein whereas no
overt changes at transcriptional level were detected (Gurha et al.,
2013); it is therefore tempting to investigate whether inhibition
of miR-22 would represent a novel myoprotective mechanism of
resveratrol.
Foxo transcription factors are known to regulate the
expression of apoptotic and atrophic genes. While earlier efforts
have elucidated that the promoter binding activity of Foxo1
was compromised in Foxo1AAA/Arg215 mutants (Schmoll et al.,
2000) and that the transcript level of Bim was decreased in
myotubes transfected with Foxo1AAA/Arg215 (McLoughlin et al.,
2009); the current work provided the first evidence that the
increase in nuclear Foxo3a was paralleled by transactivation
of Bim in the skeletal muscle during compression injury. We
also found that resveratrol blunted the decreases in cytoplasmic
levels of phosphorylated and total Foxo3a in the compressed
muscle; which could be plausibly accounted by the degradation
of Foxo3a following its deacetylation by SIRT1 and subsequent
preferential binding of Skp2 subunit of E3 ubiquitin ligase
(Wang et al., 2012). Another line of evidence has documented
that a 48-h fasting induced functional deteriorations of the
heart in Foxo1(3A/LXXAA) mice with impaired SIRT1-Foxo1
interaction but not in the wild type counterparts (Hariharan
et al., 2010). Taken together, SIRT1-mediated deacetylation of
Foxo1 may represent an important therapeutic mechanism of
resveratrol in muscle disorders; although whether these findings
would be extrapolated in compression-induced injury in the
skeletal muscle warrant further research.
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